A low-dose, single-pill combination proved to be as effective as — and in some cases, superior to — standard-dose monotherapy ...

MARYSVILLE, OH - February 24, 2026 - PRESSADVANTAGE - Sleep Better Marysville has announced the expansion of its sleep ...

New research talks about a promising adjunctive treatment to help people to build a life that isn't run by OCD.

Science’s success at staving off death from heart disease or cancer has made another diagnosis more likely: Dementia.

Rare diseases often hide in plain sight — behind delayed milestones, feeding difficulties or symptoms that seem minor at first glance. Lesch-Nyhan Syndrome (LNS ...

MicroTransponder, Inc., a commercial-stage medical device company today announced that it has changed its corporate name to Mobia Medical, Inc. (“Mobia”), effectively immediately. The Company develops ...

Up to 75% of adolescents experience sleep-related problems, including insufficient duration and poor sleep quality. At the ...

Dosing of Cohort 1 complete with first three patients having received starting dose of JAG201 delivered via intracerebroventricular (ICV) injectionFirst two patients in dose-escalation Cohort 2 have ...

Acalabrutinib (Calquence; AstraZeneca) demonstrated a more modest ORR of 40% in a smaller 25-patient cohort, with median progression-free survival (PFS) of 3.2 months. While less robust than ...

Interventions to promote the use of cardiac rehabilitation (CR) programmes may increase enrolment of patients. The interventions probably lead to small increases in patients' attendance of CR ...

Exercise for arthritis pain may be “minimal and short-lived,” claims a new umbrella study, but rheumatologists say the full ...

A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of ...